Search Results - "Confalonieri, P."

A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids by Salton, F., Rispoli, M., Confalonieri, P., De Nes, A., Spagnol, E., Salotti, A., Ruaro, B., Harari, S., Rocca, A., A. d'Onofrio, Manzoni, L., Confalonieri, M.

“…BACKGROUND The impact of severe COVID-19 pneumonia on healthcare systems highlighted the need for accurate predictions to improve patient outcomes. Despite the…”
Get full text

Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies by CAPPELLETTI, C, BAGGI, F, MANTEGAZZA, R, BERNASCONI, P, ZOLEZZI, F, BIANCOLINI, D, BERETTA, O, SEVERA, M, COCCIA, E. M, CONFALONIERI, P, MORANDI, L, MORA, M

“…Juvenile dermatomyositis (JDM), adult dermatomyositis, and polymyositis (PM) are idiopathic inflammatory myopathies (IIMs) characterized by muscle infiltration…”
Get full text

WITHDRAWN: Local dynamic stability of gait in people with early multiple sclerosis and minimal impairment. A cross-sectional study by Caronni, A, Gervasoni, E, Ferrarin, M, Anastasi, D, Brichetto, G, Confalonieri, P, Di Giovanni, R, Prosperini, L, Tacchino, A, Solaro, C, Rovaris, M, Cattaneo, D, Carpinella, I

“…This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier…”
Get full text

Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness by Brambilla, L, Sebastiano, D. Rossi, Aquino, D, Clerici, V. Torri, Brenna, G, Moscatelli, M, Frangiamore, R, Giovannetti, A.M, Antozzi, C, Mantegazza, R, Franceschetti, S, Bruzzone, M.G, Erbetta, A, Confalonieri, P

“…Abstract Background 4-aminopyridine (4-AP) is a potassium-channel blocker able to enhance walking speed in MS improving the action potentials of demyelinated…”
Get full text

Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job) by Raggi, A., Giovannetti, A. M., Schiavolin, S., Confalonieri, P., Brambilla, L., Brenna, G., Cortese, F., Covelli, V., Frangiamore, R., Moscatelli, M., Ponzio, M., Torri Clerici, V., Zaratin, P., Mantegazza, R., Leonardi, M.

“…Objective Multiple sclerosis (MS) affects young adults of working age. Difficulties in work‐related activities are usually ascribed to MS symptoms, while the…”
Get full text

Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories by Giovannetti, A. M., Pietrolongo, E., Giordano, A., Cimino, V., Campanella, A., Morone, G., Fusco, A., Lugaresi, A., Confalonieri, P., Patti, F., Grasso, M. G., Ponzio, M., Veronese, S., Solari, A.

“…Purpose Individualized quality of life (QoL) measures differ from traditional inventories in that QoL domains/weights are not predetermined, but identified by…”
Get full text

An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care by Solari, A., Martinelli, V, Trojano, M, Lugaresi, A, Granella, F, Giordano, A, Messmer Uccelli, M, D'Alessandro, R, Pucci, E, Confalonieri, P, Borreani, C

“…Background: Patients report information deficits in the period surrounding diagnosis of multiple sclerosis (MS). We assessed the effectiveness of an add-on…”
Get full text

Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration? by Zecca, Chiara, Bellavia, G., Brambilla, L., Gutierrez, L. P., Gerardi, C., Fiori, A. M., Bernardini, L. R., Camera, G., Disanto, G., Petrini, L., Perugini, J., Antozzi, C. G., Torri Clerici, V., Bellino, A., Confalonieri, P. A., Gobbi, C., Mantegazza, R. E., Rossi, S.

“…Background Glatiramer acetate (GA) 20 mg/day (GA20) is associated with immediate post-injection reactions (PIRs). For convenience of use, approved GA 40 mg…”
Get full text

Development of a shortened version of the MSQOL-54 using factor analysis and item response theory by Solari, A, Testa, S, Bertolotto, A, Confalonieri, P, Patti, F, Lugaresi, A, Grasso, M.G, Vickrey, B, Toscano, A, Giordano, A, Rosato, R

Get full text

Implementation of the ‘Sapere Migliora’ information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial by Giordano, A, Lugaresi, A, Confalonieri, P, Granella, F, Radice, D, Trojano, M, Martinelli, V, Solari, A, Giordano, A, Martinelli, V, Lugaresi, A, Pucci, E, Granella, F, Trojano, M, Solari, A, Messmer Uccelli, M, Ferrari, G, Martini, F, Radice, D, D’Annunzio, G, Farina, D, Travaglini, D, Pietrolongo, E, Onofrj, M, Torri Clerici, V, Bonanno, S, Brambilla, L, Confalonieri, P, Radaelli, M, Messina, J, Comi, G, Tortorella, C, Luciannatelli, E, Senesi, C, Tsantes, E, Conti, MZ, Rottoli, MR, Bellantonio, P, Fischetti, M, Fantozzi, R, Pala, A, Traccis, S, Di Battista, G, Bianchi, M, Benedetti, MD, Gaetani, L, Di Filippo, M, Carolei, A, Totaro, R, Lanzillo, R, Brescia Morra, V, Coppola, R, Cottone, S, Chiavazza, C, Cavalla, P, Leonardi, C, Aguglia, U, Ziuliani, C, Valla, P, Sasanelli, F, Valentino, P, Quattrone, A, Martino, Policlinico G., Russo, M, Vita, G, Immovilli, P

“…Background: The SIMS-Trial showed that the ‘Sapere Migliora’ information aid (IA) for newly diagnosed people with multiple sclerosis (PwMS) effectively…”
Get full text

Allergy and multiple sclerosis: a population-based case-control study by Pedotti, R, Farinotti, M, Falcone, C, Borgonovo, L, Confalonieri, P, Campanella, A, Mantegazza, R, Pastorello, E, Filippini, G

“…Background Epidemiological studies on the association between allergic disorders, T-helper type 2 (Th2) mediated, and multiple sclerosis (MS), a T-helper type…”
Get full text

The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients by Giordano, A., Messmer Uccelli, M., Pucci, E., Martinelli, V., Borreani, C., Lugaresi, A., Trojano, M., Granella, F., Confalonieri, P., Radice, D., Solari, A.

“…There are few studies on patient knowledge in multiple sclerosis (MS), and only two published questionnaires. The objective of this article was to develop and…”
Get full text

P.12.4 Great phenotypic variability in two siblings affected by congenital myasthenic syndrome associated with mutations in MUSK by Maggi, L, Brugnoni, R, Confalonieri, P, Scaioli, V, Morandi, L, Engel, A.G, Mantegazza, R, Bernasconi, P

“…Congenital myasthenic syndromes (CMS) are rare genetic diseases, in which neuromuscular transmission is impaired. To date 17 CMS disease genes have been…”
Get full text

Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial' by Solari, A, Giordano, A, Grasso, M G, Confalonieri, P, Patti, F, Lugaresi, A, Palmisano, L, Amadeo, R, Martino, G, Ponzio, M, Casale, G, Borreani, C, Causarano, R, Veronese, S, Zaratin, P, Battaglia, M A

Get full text

P.21.1 Autophagy as a link between immunity and inflammation in idiopathic inflammatory myopathies by Cappelletti, C, Vattemi, G.N.A, Tonin, P, Salerno, F, Kapetis, D, Maggi, L, Confalonieri, P, Morandi, L, Mora, M, Tomelleri, G, Mantegazza, R, Bernasconi, P

“…Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of immune-mediated muscle disorders characterized by muscle inflammation and weakness. They…”
Get full text

Role of tumour necrosis factor α, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach by Pierno, S., Nico, B., Burdi, R., Liantonio, A., Didonna, M. P., Cippone, V., Fraysse, B., Rolland, J.-F., Mangieri, D., Andreetta, F., Ferro, P., Camerino, C., Zallone, A., Confalonieri, P., De Luca, A.

“…The role of tumour necrosis factor (TNF)‐α or cyclo‐oxygenase‐2 (COX‐2) eicosanoids in dystrophinopathies has been evaluated by chronically treating (4–8…”
Get full text

Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis by ANTOZZI, C, GRANATA, T, AURISANO, N, ZARDINI, G, CONFALONIERI, P, AIRAGHI, G, MANTEGAZZA, R, SPREAFICO, R

Get full text

Modified lotus petal flap for vulvo-vaginal reconstruction after resection for vulvar cancer: a single institution experience by Misani, M, Rovati, L C V, Confalonieri, P, Buda, A, Giuliani, D, Del Bene, M

Get more information

Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis by Confalonieri, Maiocchi, Salton, Ruaro, Rizzardi, Volpe, Licastro, Braga, Confalonieri

Get full text

G.P.6.08 Comparison of the effects of chronic treatments with drugs targeting different disease-related pathways in dystrophic mdx mice by Rolland, J, Burdi, R, Cozzoli, A, Giannuzzi, V, Liantonio, A, Cippone, V, Mangieri, D, Camerino, G, Nicchia, G, Frigeri, A, Andreetta, F, Confalonieri, P, Nico, B, De Luca, A

Get full text